InfraReDx Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:InfraReDx Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010986
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Infraredx Inc (Infraredx), a subsidiary of Nipro Corp is a medical device company that provides cardiovascular imaging solutions. The company offers TVC imaging system, a dual-modality intravascular imaging system that assesses plaque composition and vessel structure. Its TVC imaging system provides identification and location of LCP and quantification of the vessel’s lipid core burden. Infraredx also offers NIR coronary imaging system and IVUS coronary imaging system. The company provides optimization of coronary stenting procedures and post-stenting management services. It operates in the Netherlands, Czech Republic, Italy, South Korea, and Japan. Infraredx is headquartered in Burlington, Massachusetts, the US.

InfraReDx Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InfraReDx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
InfraReDx Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
InfraReDx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
InfraReDx Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
InfraReDx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
InfraReDx Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Nipro Invests US$25 Million In Infraredx 10
InfraReDx Secures US$24.1 Million In Financing 11
Partnerships 12
Infraredx Enters into R&D Agreement with Massachusetts General Hospital 12
Koninklijke Royal Philips And Infraredx Enter Into Agreement For Imaging System And X-ray Systems 13
Infraredx Enters Into Co-Development Agreement With Philips 14
Infraredx Enters Into Distribution Agreement With Nipro For TVC Imaging System 15
Equity Offering 16
Infraredx Withdraws IPO 16
Acquisition 17
Nipro to Acquire Infraredx 17
InfraReDx Inc – Key Competitors 18
InfraReDx Inc – Key Employees 19
InfraReDx Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
InfraReDx Inc, Medical Equipment, Key Facts 2
InfraReDx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
InfraReDx Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
InfraReDx Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
InfraReDx Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
InfraReDx Inc, Deals By Market, 2011 to YTD 2017 8
InfraReDx Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Nipro Invests US$25 Million In Infraredx 10
InfraReDx Secures US$24.1 Million In Financing 11
Infraredx Enters into R&D Agreement with Massachusetts General Hospital 12
Koninklijke Royal Philips And Infraredx Enter Into Agreement For Imaging System And X-ray Systems 13
Infraredx Enters Into Co-Development Agreement With Philips 14
Infraredx Enters Into Distribution Agreement With Nipro For TVC Imaging System 15
Infraredx Withdraws IPO 16
Nipro to Acquire Infraredx 17
InfraReDx Inc, Key Competitors 18
InfraReDx Inc, Key Employees 19
InfraReDx Inc, Subsidiaries 20

★海外企業調査レポート[InfraReDx Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • McKesson Corp (MCK):医療機器:M&Aディール及び事業提携情報
    Summary McKesson Corp (McKesson) is a provider of healthcare services and information technology solutions. It distributes pharmaceuticals, medical equipment, and health and beauty care products in North America and overseas. The company also develops and provides decision support software and syste …
  • Eddie Stobart Logistics plc:企業の戦略・SWOT・財務情報
    Eddie Stobart Logistics plc - Strategy, SWOT and Corporate Finance Report Summary Eddie Stobart Logistics plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Euroclear Plc:企業の戦略・SWOT・財務分析
    Euroclear Plc - Strategy, SWOT and Corporate Finance Report Summary Euroclear Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Saudi Basic Industries Corporation:企業の戦略・SWOT・財務分析
    Saudi Basic Industries Corporation - Strategy, SWOT and Corporate Finance Report Summary Saudi Basic Industries Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Glenmark Pharmaceuticals Limited:企業のM&A・事業提携・投資動向
    Glenmark Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Glenmark Pharmaceuticals Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Senju Pharmaceutical Co Ltd:企業の戦略的SWOT分析
    Senju Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Cancer Research UK-製薬・医療分野:企業M&A・提携分析
    Summary Cancer Research UK (CRUK) is a research institution which offers clinical research services to treat cancer. The institute offers research services for womb cancer, lung cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children's ca …
  • Sientra Inc (SIEN):企業の財務・戦略的SWOT分析
    Summary Sientra Inc (Sientra) is a medical device company that manufactures and markets plastic surgery implantable devices. The company’s products comprise breast implants, breast tissue expanders, silicone scar treatment and additional tissue expanders. It offers reconstructive surgery devices suc …
  • OraSure Technologies Inc (OSUR):企業の財務・戦略的SWOT分析
    OraSure Technologies Inc (OSUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Novant Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Novant Health Inc (Novant Health) is a not-for-profit, integrated healthcare service provider. The organization provides services related to assisted living, blood services, breast health, children’s services, laboratory services, emergency, laboratory services, cancer, urgent care, hospice …
  • Carr’s Group Plc (CARR):企業の財務・戦略的SWOT分析
    Carr's Group Plc (CARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Centrica Plc (CNA):企業の財務・戦略的SWOT分析
    Centrica Plc (CNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Verona Pharma Plc (VRP)-製薬・医療分野:企業M&A・提携分析
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Abaxis Inc:企業の戦略的SWOT分析
    Abaxis Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Saudi Telecom Co (7010):企業の財務・戦略的SWOT分析
    Saudi Telecom Co (7010) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Bancolombia SA (BCOLOMBIA):企業の財務・戦略的SWOT分析
    Bancolombia SA (BCOLOMBIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Rohto Pharmaceutical Co Ltd (4527):企業の財務・戦略的SWOT分析
    Rohto Pharmaceutical Co Ltd (4527) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Provectus Biopharmaceuticals Inc (PVCT)-医療機器分野:企業M&A・提携分析
    Summary Provectus Biopharmaceuticals Inc (Provectus), formerly Provectus pharmaceuticals Inc is a biotechnology company that develops pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for recurrent melanoma, PV-10 for metastatic liver canc …
  • Nippon Soda Co., Ltd.:企業の戦略・SWOT・財務分析
    Nippon Soda Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Soda Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Vetoquinol SA (VETO):企業の財務・戦略的SWOT分析
    Summary Vetoquinol SA (Vetoquinol) is a veterinary pharmaceutical company that develops, produces and distributes veterinary drugs and non-medicinal products. The company provides pain management, anti-infective, hygiene and care, pest control, behavior, internal medicine, reproduction, behaviour an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆